Drug Topics May 7, 2024
The specialty drug market has exploded in the last few decades.
Natalie Bedford, Senior Vice President, US Pharmaceutical Distribution Services at McKesson, sat down with Drug Topics at AXS24, the Asembia Specialty Pharmacy Summit, to discuss the growth of the specialty drug market and the ways McKesson is helping manufacturing partners navigate regulatory changes.
Drug Topics: What are some medications that have seen the most growth recently?
Natalie Bedford: That’s a fun question. Let me take a walk [through] history. When you look back at the specialty market—when you look at 1990—there were maybe about 10 specialty drugs on the market. Fast forward to 2008, roughly 200 [drugs], 2015, another 100 come to market, [so] about 300 [total]. And then...